{"id":"https://openalex.org/W2947713247","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2075","title":"A phase Ib trial of CB-839 (telaglenastat) in combination with radiation therapy and temozolomide in patients with IDH-mutated diffuse astrocytoma and anaplastic astrocytoma (NCT03528642).","display_name":"A phase Ib trial of CB-839 (telaglenastat) in combination with radiation therapy and temozolomide in patients with IDH-mutated diffuse astrocytoma and anaplastic astrocytoma (NCT03528642).","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2947713247","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2075","mag":"2947713247"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.tps2075","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2075","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2075","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031473630","display_name":"Sani Haider Kizilbash","orcid":"https://orcid.org/0000-0001-8568-1519","observed_orcids":["https://orcid.org/0000-0001-8568-1519"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sani Haider Kizilbash","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022454220","display_name":"Samuel K. McBrayer","orcid":"https://orcid.org/0000-0001-9361-675X","observed_orcids":["https://orcid.org/0000-0001-9361-675X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel McBrayer","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004258810","display_name":"John D. Port","orcid":"https://orcid.org/0000-0002-4237-7776","observed_orcids":["https://orcid.org/0000-0002-4237-7776"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Port","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027416118","display_name":"Joel M. Reid","orcid":"https://orcid.org/0000-0003-2872-3123","observed_orcids":["https://orcid.org/0000-0003-2872-3123"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel M. Reid","raw_affiliation_strings":["Department of Oncology, Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086048227","display_name":"Ian R. Lanza","orcid":"https://orcid.org/0000-0002-9858-3384","observed_orcids":["https://orcid.org/0000-0002-9858-3384"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ian Lanza","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109347815","display_name":"Jacob B. Allred","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob B Allred","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018381770","display_name":"Arnab Chakravarti","orcid":"https://orcid.org/0000-0002-5392-8721","observed_orcids":["https://orcid.org/0000-0002-5392-8721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arnab Chakravarti","raw_affiliation_strings":["Ohio State Univ-Arthur G. James Cancer Ctr, Dublin, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State Univ-Arthur G. James Cancer Ctr, Dublin, OH;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042269391","display_name":"Charles A. Kunos","orcid":"https://orcid.org/0009-0004-4056-9004","observed_orcids":["https://orcid.org/0009-0004-4056-9004"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Kunos","raw_affiliation_strings":["National Cancer Institute, Rockville, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, Rockville, MD;","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113962365","display_name":"Alex A. Adjei","orcid":"https://orcid.org/0000-0002-8039-6556","observed_orcids":["https://orcid.org/0000-0002-8039-6556"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex A. Adjei","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"TPS2075","last_page":"TPS2075"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/telaglenastat","display_name":"telaglenastat","score":0.8859999775886536},{"id":"https://openalex.org/keywords/cb-839","display_name":"CB-839","score":0.9990000128746033},{"id":"https://openalex.org/keywords/idh-mutant-astrocytoma","display_name":"IDH-mutant astrocytoma","score":0.8740000128746033},{"id":"https://openalex.org/keywords/anaplastic-astrocytoma","display_name":"anaplastic astrocytoma","score":0.9670000076293945},{"id":"https://openalex.org/keywords/glutaminase-inhibitors","display_name":"glutaminase inhibitors","score":0.7820000052452087},{"id":"https://openalex.org/keywords/2-hydroxyglutarate","display_name":"2-hydroxyglutarate","score":0.9559999704360962},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.6880000233650208},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/concurrent-chemoradiotherapy","display_name":"concurrent chemoradiotherapy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8399999737739563},{"id":"https://openalex.org/keywords/tumor-metabolome","display_name":"tumor metabolome","score":0.6359999775886536},{"id":"https://openalex.org/keywords/plasma-metabolomics","display_name":"plasma metabolomics","score":0.734000027179718},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9120000004768372},{"id":"https://openalex.org/keywords/neurocognitive-toxicity","display_name":"neurocognitive toxicity","score":0.8100000023841858},{"id":"https://openalex.org/keywords/glioma","display_name":"glioma","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.7074788808822632},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6950060129165649},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.6796597242355347},{"id":"https://openalex.org/C2779083369","wikidata":"https://www.wikidata.org/wiki/Q486092","display_name":"Anaplastic astrocytoma","level":4,"score":0.5678984522819519},{"id":"https://openalex.org/C2779349466","wikidata":"https://www.wikidata.org/wiki/Q181619","display_name":"Glutamine","level":3,"score":0.5030006766319275},{"id":"https://openalex.org/C2779434656","wikidata":"https://www.wikidata.org/wiki/Q415378","display_name":"Lomustine","level":5,"score":0.4985544681549072},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4909832775592804},{"id":"https://openalex.org/C2778880634","wikidata":"https://www.wikidata.org/wiki/Q177755","display_name":"Astrocytoma","level":3,"score":0.4872547686100006},{"id":"https://openalex.org/C135870905","wikidata":"https://www.wikidata.org/wiki/Q903667","display_name":"Metabolome","level":3,"score":0.4858550727367401},{"id":"https://openalex.org/C109549099","wikidata":"https://www.wikidata.org/wiki/Q24773687","display_name":"Glutaminase","level":4,"score":0.4197508692741394},{"id":"https://openalex.org/C2778160063","wikidata":"https://www.wikidata.org/wiki/Q1532402","display_name":"Glutaminolysis","level":4,"score":0.41614168882369995},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3795544505119324},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3598563075065613},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3359535336494446},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.2985433042049408},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.28857457637786865},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.257429838180542},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.20049533247947693},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.18317702412605286},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.18314436078071594},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.1348269283771515},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13307681679725647},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.09947755932807922},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.tps2075","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2075","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2075","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.7400000095367432,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4308977956","https://openalex.org/W2956057309","https://openalex.org/W2899912694","https://openalex.org/W7162679041","https://openalex.org/W2947315175","https://openalex.org/W7169654212","https://openalex.org/W2029722190","https://openalex.org/W4309017997","https://openalex.org/W3123903218","https://openalex.org/W647032997"],"abstract_inverted_index":{"TPS2075":[0],"Background:":[1],"IDH":[2,78,121,193],"mutant":[3,79,122,194],"astrocytomas":[4,132],"express":[5],"high":[6],"levels":[7],"of":[8,109,141,147,177,190,215,224,247],"2-hydroxyglutarate":[9],"(2-HG),":[10],"an":[11,89,179],"oncogenic":[12],"metabolite":[13],"which":[14,25,57],"drives":[15],"gliomagenesis.":[16],"Excess":[17],"2-HG":[18],"inhibits":[19],"branched":[20,30],"chain":[21,31],"amino":[22,32],"acid":[23],"transaminase,":[24],"catalyzes":[26],"glutamate":[27,46,74],"synthesis":[28],"from":[29,48],"acids.":[33],"This":[34],"defect":[35],"causes":[36],"these":[37],"tumors":[38],"to":[39,197,220,244,266],"become":[40],"more":[41],"reliant":[42],"on":[43,165,226,252],"glutaminase":[44,55],"for":[45,264],"biosynthesis":[47],"glutamine.":[49],"CB-839":[50,70,110,150,216,225],"(telaglenastat)":[51],"is":[52,58,96,261],"a":[53,97,166,211],"novel":[54],"inhibitor":[56],"well":[59],"tolerated":[60,174],"in":[61,77,88,116,162,232],"humans.":[62],"McBrayer":[63],"et":[64],"al":[65],"have":[66],"recently":[67],"demonstrated":[68],"that":[69],"further":[71],"depletes":[72],"intracellular":[73],"and":[75,82,107,130,138,186,204,236],"glutathione":[76],"glioma":[80,91],"cells,":[81],"enhances":[83],"RT":[84],"(radiation":[85],"therapy)":[86],"efficacy":[87],"orthotopic":[90],"model.":[92],"Methods:":[93],"NCI":[94,259],"#10218":[95,260],"CTEP":[98],"supported":[99],"phase":[100],"I":[101],"clinical":[102],"trial":[103,270],"investigating":[104],"the":[105,172,184,227],"safety":[106],"tolerability":[108],"when":[111],"combined":[112],"with":[113,118,127,136,144,157,159,192,210,242],"RT/TMZ":[114],"(temozolomide)":[115],"patients":[117,191,205],"previously":[119],"untreated":[120],"grade":[123,128],"II/III":[124],"astrocytoma.":[125,195],"Patients":[126],"II":[129],"III":[131],"will":[133,151,182,200,206,229,255],"be":[134,153,208,230,257],"treated":[135,209],"50.4":[137],"59.4":[139],"Gy":[140],"RT,":[142,158],"respectively,":[143],"standard":[145,167],"doses":[146,160],"concurrent":[148],"TMZ.":[149],"also":[152,256],"administered":[154],"orally":[155],"concurrently":[156],"escalated":[161],"cohorts":[163],"based":[164],"3+3":[168],"design.":[169],"After":[170],"defining":[171],"maximum":[173],"dose":[175],"(MTD)":[176],"CB-839,":[178],"expansion":[180],"cohort":[181,199,267],"evaluate":[183],"pre-":[185],"post-CB-839":[187],"therapy":[188],"metabolome":[189,228],"Enrollment":[196],"this":[198],"require":[201],"measurable":[202],"disease":[203],"additionally":[207],"7":[212],"day":[213],"run-in":[214],"at":[217],"MTD":[218],"prior":[219],"RT.":[221],"The":[222],"effect":[223],"studied":[231],"both":[233],"plasma":[234],"(LC/MS/MS)":[235],"tumor":[237],"(magnetic":[238],"resonance":[239],"spectroscopy),":[240],"along":[241],"PK":[243],"confirm":[245],"adequacy":[246],"systemic":[248],"exposure.":[249],"Preliminary":[250],"data":[251],"neurocognitive":[253],"endpoints":[254],"acquired.":[258],"currently":[262],"activated":[263],"enrollment":[265],"1.":[268],"Clinical":[269],"information:":[271],"NCT03528642.":[272]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2019-06-07T00:00:00"}